Showing results (171-180 of 301) with videos related to
Sort By:
Pageof 31
Cancer Immunology, Immunotherapy : CII|May 4, 2005
Combination therapy using the cyclooxygenase-2 inhibitor Parecoxib and radioimmunotherapy in nude mice with small peritoneal metastases of colonic originManuel J Koppe, Wim J G Oyen, Robert P Bleichrodt, et al.Cancer Research|August 19, 2017
Combination Therapy with Bispecific Antibodies and PD-1 Blockade Enhances the Antitumor Potency of T CellsChien-Hsing Chang, Yang Wang, Rongxiu Li, et al.Cancer|February 4, 2010
Three methods assessing red marrow dosimetry in lymphoma patients treated with radioimmunotherapyLudovic Ferrer, Françoise Kraeber-Bodéré, Caroline Bodet-Milin, et al.JAMA Dermatology|August 19, 2014
Subcutaneous veltuzumab, a humanized anti-CD20 antibody, in the treatment of refractory pemphigus vulgarisChristoph T Ellebrecht, Eun J Choi, David M Allman, et al.Haematologica|August 24, 2014
Anti-CD22 90Y-epratuzumab tetraxetan combined with anti-CD20 veltuzumab: a phase I study in patients with relapsed/refractory, aggressive non-Hodgkin lymphomaThomas E Witzig, Michael B Tomblyn, Jamal G Misleh, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 19, 2007
CD74: a new candidate target for the immunotherapy of B-cell neoplasmsRhona Stein, M Jules Mattes, Thomas M Cardillo, et al.British Journal of Haematology|October 12, 2013
Phase I, multicentre, dose-escalation trial of monotherapy with milatuzumab (humanized anti-CD74 monoclonal antibody) in relapsed or refractory multiple myelomaJonathan L Kaufman, Ruben Niesvizky, Edward A Stadtmauer, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 23, 2004
Characterization of a new humanized anti-CD20 monoclonal antibody, IMMU-106, and Its use in combination with the humanized anti-CD22 antibody, epratuzumab, for the therapy of non-Hodgkin's lymphomaRhona Stein, Zhengxing Qu, Susan Chen, et al.Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|January 28, 2017
Detection of Micrometastases Using SPECT/Fluorescence Dual-Modality Imaging in a CEA-Expressing Tumor ModelMarlène C H Hekman, Mark Rijpkema, Desirée L Bos, et al.International Journal of Cancer|August 15, 2003
Experimental radioimmunotherapy of small peritoneal metastases of colorectal originManuel J Koppe, Annemieke C Soede, Wikke Pels, et al.Pageof 31